APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human Endostatin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Recombinant Human Endostatin Industry Growth and Trends Forecast to 2032

26 December 202579 pages

Choose your research edition.

Industry ResearchRecombinant Human Endostatin Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human Endostatin Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Recombinant Human Endostatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human Endostatin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human Endostatin Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Recombinant Human Endostatin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Recombinant Human Endostatin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Recombinant Human Endostatin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Human Endostatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Human Endostatin include Thermo Fisher Scientific and PeproTech among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Recombinant Human Endostatin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Recombinant Human Endostatin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant Human Endostatin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant Human Endostatin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Recombinant Human Endostatin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Recombinant Human Endostatin Market by Company

Thermo Fisher Scientific

PeproTech

Recombinant Human Endostatin Segment by Type

Purity:95%

Others

Recombinant Human Endostatin Segment by Application

Medical Care

Scientific Research

Others

Recombinant Human Endostatin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human Endostatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human Endostatin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human Endostatin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Human Endostatin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Recombinant Human Endostatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity:95% Table 2. Major Company of Others Table 3. Global Recombinant Human Endostatin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Recombinant Human Endostatin Sales by Type (2021-2026) & (K Units) Table 5. Global Recombinant Human Endostatin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Recombinant Human Endostatin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Recombinant Human Endostatin Sales Market Share in Value by Type (2021-2026) Table 8. Global Recombinant Human Endostatin Price by Type (2021-2026) & (US$/Unit) Table 9. Global Recombinant Human Endostatin Sales by Type (2027-2032) & (K Units) Table 10. Global Recombinant Human Endostatin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Recombinant Human Endostatin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Recombinant Human Endostatin Sales Market Share in Value by Type (2027-2032) Table 13. Global Recombinant Human Endostatin Price by Type (2027-2032) & (US$/Unit) Table 14. North America Recombinant Human Endostatin Sales by Type (2021-2026) & (K Units) Table 15. North America Recombinant Human Endostatin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Recombinant Human Endostatin Sales by Type (2021-2026) & (K Units) Table 17. Europe Recombinant Human Endostatin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Recombinant Human Endostatin Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Recombinant Human Endostatin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Recombinant Human Endostatin Sales by Type (2021-2026) & (K Units) Table 21. Latin America Recombinant Human Endostatin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Recombinant Human Endostatin Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Recombinant Human Endostatin Sales by Type (2021-2026) & (US$ Million) Table 24. Recombinant Human Endostatin Industry Trends Table 25. Recombinant Human Endostatin Industry Drivers Table 26. Recombinant Human Endostatin Industry Opportunities and Challenges Table 27. Recombinant Human Endostatin Industry Restraints Table 28. Global Recombinant Human Endostatin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Recombinant Human Endostatin Revenue Market Share by Company (2021-2026) Table 30. Global Recombinant Human Endostatin Sales by Company (2021-2026) & (K Units) Table 31. Global Recombinant Human Endostatin Sales Share by Company (2021-2026) Table 32. Global Recombinant Human Endostatin Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Recombinant Human Endostatin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Recombinant Human Endostatin Major Company Production Sites and Headquarters Table 35. Global Recombinant Human Endostatin Company, Product Type & Application Table 36. Global Recombinant Human Endostatin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Recombinant Human Endostatin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Recombinant Human Endostatin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Recombinant Human Endostatin Sales by Region (2021-2026) & (K Units) Table 41. Global Recombinant Human Endostatin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Recombinant Human Endostatin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Recombinant Human Endostatin Sales Market Share in Value by Region (2021-2026) Table 44. Global Recombinant Human Endostatin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Recombinant Human Endostatin Sales by Region (2027-2032) & (K Units) Table 46. Global Recombinant Human Endostatin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Recombinant Human Endostatin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Recombinant Human Endostatin Sales Market Share in Value by Region (2027-2032) Table 49. Global Recombinant Human Endostatin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Recombinant Human Endostatin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Recombinant Human Endostatin Sales by Application (2021-2026) & (K Units) Table 52. Global Recombinant Human Endostatin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Recombinant Human Endostatin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Recombinant Human Endostatin Sales Market Share in Value by Application (2021-2026) Table 55. Global Recombinant Human Endostatin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Recombinant Human Endostatin Sales by Application (2027-2032) & (K Units) Table 57. Global Recombinant Human Endostatin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Recombinant Human Endostatin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Recombinant Human Endostatin Sales Market Share in Value by Application (2027-2032) Table 60. Global Recombinant Human Endostatin Price by Application (2027-2032) & (US$/Unit) Table 61. North America Recombinant Human Endostatin Sales by Application (2021-2026) & (K Units) Table 62. North America Recombinant Human Endostatin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Recombinant Human Endostatin Sales by Application (2021-2026) & (K Units) Table 64. Europe Recombinant Human Endostatin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Recombinant Human Endostatin Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Recombinant Human Endostatin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Recombinant Human Endostatin Sales by Application (2021-2026) & (K Units) Table 68. Latin America Recombinant Human Endostatin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Recombinant Human Endostatin Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Recombinant Human Endostatin Sales by Application (2021-2026) & (US$ Million) Table 71. Thermo Fisher Scientific Company Information Table 72. Thermo Fisher Scientific Business Overview Table 73. Thermo Fisher Scientific Recombinant Human Endostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Thermo Fisher Scientific Recombinant Human Endostatin Product Portfolio Table 75. Thermo Fisher Scientific Recent Development Table 76. PeproTech Company Information Table 77. PeproTech Business Overview Table 78. PeproTech Recombinant Human Endostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. PeproTech Recombinant Human Endostatin Product Portfolio Table 80. PeproTech Recent Development Table 81. North America Recombinant Human Endostatin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 82. North America Recombinant Human Endostatin Sales by Country (2021-2026) & (K Units) Table 83. North America Recombinant Human Endostatin Sales Market Share by Country (2021-2026) Table 84. North America Recombinant Human Endostatin Sales Forecast by Country (2027-2032) & (K Units) Table 85. North America Recombinant Human Endostatin Sales Market Share Forecast by Country (2027-2032) Table 86. North America Recombinant Human Endostatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 87. North America Recombinant Human Endostatin Market Size by Country (2021-2026) & (US$ Million) Table 88. North America Recombinant Human Endostatin Market Share by Country (2021-2026) Table 89. North America Recombinant Human Endostatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 90. North America Recombinant Human Endostatin Market Share Forecast by Country (2027-2032) Table 91. Europe Recombinant Human Endostatin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. Europe Recombinant Human Endostatin Sales by Country (2021-2026) & (K Units) Table 93. Europe Recombinant Human Endostatin Sales Market Share by Country (2021-2026) Table 94. Europe Recombinant Human Endostatin Sales Forecast by Country (2027-2032) & (K Units) Table 95. Europe Recombinant Human Endostatin Sales Market Share Forecast by Country (2027-2032) Table 96. Europe Recombinant Human Endostatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. Europe Recombinant Human Endostatin Market Size by Country (2021-2026) & (US$ Million) Table 98. Europe Recombinant Human Endostatin Market Share by Country (2021-2026) Table 99. Europe Recombinant Human Endostatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. Europe Recombinant Human Endostatin Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Recombinant Human Endostatin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Recombinant Human Endostatin Sales by Country (2021-2026) & (K Units) Table 103. Asia-Pacific Recombinant Human Endostatin Sales Market Share by Country (2021-2026) Table 104. Asia-Pacific Recombinant Human Endostatin Sales Forecast by Country (2027-2032) & (K Units) Table 105. Asia-Pacific Recombinant Human Endostatin Sales Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Recombinant Human Endostatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Recombinant Human Endostatin Market Size by Country (2021-2026) & (US$ Million) Table 108. Asia-Pacific Recombinant Human Endostatin Market Share by Country (2021-2026) Table 109. Asia-Pacific Recombinant Human Endostatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Asia-Pacific Recombinant Human Endostatin Market Share Forecast by Country (2027-2032) Table 111. Latin America Recombinant Human Endostatin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Latin America Recombinant Human Endostatin Sales by Country (2021-2026) & (K Units) Table 113. Latin America Recombinant Human Endostatin Sales Market Share by Country (2021-2026) Table 114. Latin America Recombinant Human Endostatin Sales Forecast by Country (2027-2032) & (K Units) Table 115. Latin America Recombinant Human Endostatin Sales Market Share Forecast by Country (2027-2032) Table 116. Latin America Recombinant Human Endostatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Latin America Recombinant Human Endostatin Market Size by Country (2021-2026) & (US$ Million) Table 118. Latin America Recombinant Human Endostatin Market Share by Country (2021-2026) Table 119. Latin America Recombinant Human Endostatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Latin America Recombinant Human Endostatin Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Recombinant Human Endostatin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Recombinant Human Endostatin Sales by Country (2021-2026) & (K Units) Table 123. Middle East and Africa Recombinant Human Endostatin Sales Market Share by Country (2021-2026) Table 124. Middle East and Africa Recombinant Human Endostatin Sales Forecast by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Recombinant Human Endostatin Sales Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Recombinant Human Endostatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Recombinant Human Endostatin Market Size by Country (2021-2026) & (US$ Million) Table 128. Middle East and Africa Recombinant Human Endostatin Market Share by Country (2021-2026) Table 129. Middle East and Africa Recombinant Human Endostatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Middle East and Africa Recombinant Human Endostatin Market Share Forecast by Country (2027-2032) Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Recombinant Human Endostatin Distributors List Table 134. Recombinant Human Endostatin Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Recombinant Human Endostatin Image Figure 2. Global Recombinant Human Endostatin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Human Endostatin Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Human Endostatin Sales (2021-2032) & (K Units) Figure 5. Purity:95% Image Figure 6. Global Purity:95% Sales YoY Growth (2021-2032) & (K Units) Figure 7. Others Image Figure 8. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Recombinant Human Endostatin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Recombinant Human Endostatin Market Share by Type 2025 VS 2032 Figure 11. North America Recombinant Human Endostatin Sales Market Share in Volume by Type in 2025 Figure 12. North America Recombinant Human Endostatin Sales Market Share in Value by Type in 2025 Figure 13. Europe Recombinant Human Endostatin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Recombinant Human Endostatin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Recombinant Human Endostatin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Recombinant Human Endostatin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Recombinant Human Endostatin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Recombinant Human Endostatin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Recombinant Human Endostatin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Recombinant Human Endostatin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Recombinant Human Endostatin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Medical Care Image Figure 24. Global Medical Care Sales YoY Growth (2021-2032) & (K Units) Figure 25. Scientific Research Image Figure 26. Global Scientific Research Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Recombinant Human Endostatin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Recombinant Human Endostatin Market Share by Application 2025 VS 2032 Figure 31. North America Recombinant Human Endostatin Sales Market Share in Volume by Application in 2025 Figure 32. North America Recombinant Human Endostatin Sales Market Share in Value by Application in 2025 Figure 33. Europe Recombinant Human Endostatin Sales Market Share in Volume by Application in 2025 Figure 34. Europe Recombinant Human Endostatin Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Recombinant Human Endostatin Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Recombinant Human Endostatin Sales Market Share in Value by Application in 2025 Figure 37. Latin America Recombinant Human Endostatin Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Recombinant Human Endostatin Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Recombinant Human Endostatin Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Recombinant Human Endostatin Sales Market Share in Value by Application in 2025 Figure 41. North America Recombinant Human Endostatin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Recombinant Human Endostatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Recombinant Human Endostatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Recombinant Human Endostatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Recombinant Human Endostatin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Recombinant Human Endostatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Recombinant Human Endostatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Recombinant Human Endostatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Recombinant Human Endostatin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Recombinant Human Endostatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Recombinant Human Endostatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Recombinant Human Endostatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Recombinant Human Endostatin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Recombinant Human Endostatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Recombinant Human Endostatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Recombinant Human Endostatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Recombinant Human Endostatin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Recombinant Human Endostatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Recombinant Human Endostatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Recombinant Human Endostatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Recombinant Human Endostatin Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Recombinant Human Endostatin Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Purity:95%
  • Others
Applications
  • Medical Care
  • Scientific Research
  • Others
Companies covered
  • Thermo Fisher Scientific
  • PeproTech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Human Endostatin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Recombinant Human Endostatin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Recombinant Human Endostatin Market by Type
  6. 1.3.1 Purity:95%
  7. 1.3.2 Others
  8. 1.4 Global Recombinant Human Endostatin Market Size by Type
  9. 1.4.1 Global Recombinant Human Endostatin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Recombinant Human Endostatin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Recombinant Human Endostatin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Recombinant Human Endostatin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Recombinant Human Endostatin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Recombinant Human Endostatin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Recombinant Human Endostatin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Recombinant Human Endostatin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Recombinant Human Endostatin Industry Trends
  2. 2.2 Recombinant Human Endostatin Industry Drivers
  3. 2.3 Recombinant Human Endostatin Industry Opportunities and Challenges
  4. 2.4 Recombinant Human Endostatin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Recombinant Human Endostatin Revenue (2021-2026)
  2. 3.2 Global Top Players by Recombinant Human Endostatin Sales (2021-2026)
  3. 3.3 Global Top Players by Recombinant Human Endostatin Price (2021-2026)
  4. 3.4 Global Recombinant Human Endostatin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Human Endostatin Major Company Production Sites & Headquarters
  6. 3.6 Global Recombinant Human Endostatin Company, Product Type & Application
  7. 3.7 Global Recombinant Human Endostatin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Human Endostatin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Human Endostatin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Human Endostatin Tier 1, Tier 2, and Tier 3
4 Recombinant Human Endostatin Regional Status and Outlook
  1. 4.1 Global Recombinant Human Endostatin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Recombinant Human Endostatin Historic Market Size by Region
  3. 4.2.1 Global Recombinant Human Endostatin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Recombinant Human Endostatin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Recombinant Human Endostatin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Recombinant Human Endostatin Forecasted Market Size by Region
  7. 4.3.1 Global Recombinant Human Endostatin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Recombinant Human Endostatin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Recombinant Human Endostatin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Recombinant Human Endostatin by Application
  1. 5.1 Recombinant Human Endostatin Market by Application
  2. 5.1.1 Medical Care
  3. 5.1.2 Scientific Research
  4. 5.1.3 Others
  5. 5.2 Global Recombinant Human Endostatin Market Size by Application
  6. 5.2.1 Global Recombinant Human Endostatin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Recombinant Human Endostatin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Recombinant Human Endostatin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Recombinant Human Endostatin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Recombinant Human Endostatin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Recombinant Human Endostatin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Recombinant Human Endostatin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Recombinant Human Endostatin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific Recombinant Human Endostatin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Recombinant Human Endostatin Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 PeproTech
  8. 6.2.1 PeproTech Company Information
  9. 6.2.2 PeproTech Business Overview
  10. 6.2.3 PeproTech Recombinant Human Endostatin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 PeproTech Recombinant Human Endostatin Product Portfolio
  12. 6.2.5 PeproTech Recent Developments
7 North America by Country
  1. 7.1 North America Recombinant Human Endostatin Sales by Country
  2. 7.1.1 North America Recombinant Human Endostatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Recombinant Human Endostatin Sales by Country (2021-2026)
  4. 7.1.3 North America Recombinant Human Endostatin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Recombinant Human Endostatin Market Size by Country
  6. 7.2.1 North America Recombinant Human Endostatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Recombinant Human Endostatin Market Size by Country (2021-2026)
  8. 7.2.3 North America Recombinant Human Endostatin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Recombinant Human Endostatin Sales by Country
  2. 8.1.1 Europe Recombinant Human Endostatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Recombinant Human Endostatin Sales by Country (2021-2026)
  4. 8.1.3 Europe Recombinant Human Endostatin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Recombinant Human Endostatin Market Size by Country
  6. 8.2.1 Europe Recombinant Human Endostatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Recombinant Human Endostatin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Recombinant Human Endostatin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Recombinant Human Endostatin Sales by Country
  2. 9.1.1 Asia-Pacific Recombinant Human Endostatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Recombinant Human Endostatin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Recombinant Human Endostatin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Recombinant Human Endostatin Market Size by Country
  6. 9.2.1 Asia-Pacific Recombinant Human Endostatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Recombinant Human Endostatin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Recombinant Human Endostatin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Recombinant Human Endostatin Sales by Country
  2. 10.1.1 South America Recombinant Human Endostatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Recombinant Human Endostatin Sales by Country (2021-2026)
  4. 10.1.3 South America Recombinant Human Endostatin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Recombinant Human Endostatin Market Size by Country
  6. 10.2.1 South America Recombinant Human Endostatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Recombinant Human Endostatin Market Size by Country (2021-2026)
  8. 10.2.3 South America Recombinant Human Endostatin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Recombinant Human Endostatin Sales by Country
  2. 11.1.1 Middle East and Africa Recombinant Human Endostatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Recombinant Human Endostatin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Recombinant Human Endostatin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Recombinant Human Endostatin Market Size by Country
  6. 11.2.1 Middle East and Africa Recombinant Human Endostatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Recombinant Human Endostatin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Recombinant Human Endostatin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Recombinant Human Endostatin Value Chain Analysis
  2. 12.1.1 Recombinant Human Endostatin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Recombinant Human Endostatin Production Mode & Process
  7. 12.2 Recombinant Human Endostatin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Recombinant Human Endostatin Distributors
  10. 12.2.3 Recombinant Human Endostatin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst